Athletigen Company

Delivering world-class DNA analysis techology to optimize performance in elite athletes and develop precision products

Investors

Technology: P4 Medicine
Industry: P4 Medicine
Headquarters: Canada
Founded Date: 2014-03-01
Employees Number: 11-50
Funding Status: Seed
Acquisitions Number: 1
Investors Number: 3
Total Funding: $1.6M
Estimated Revenue: $1M to $10M
Last Funding Type: Seed

Visit Website
contact@athletigen.com
https://twitter.com/Athletigen
Register and Claim Ownership